BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22335248)

  • 1. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOG1 expression in giant-cell-containing bone tumours.
    Cleven AH; Briaire-de Bruijn I; Szuhai K; Bovée JV
    Histopathology; 2016 May; 68(6):942-5. PubMed ID: 26402312
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
    Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
    Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
    Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
    Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
    Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
    Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroblastoma: An Update.
    Chen W; DiFrancesco LM
    Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
    Rekhi B; Dave V; Butle A; Dutt A
    Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
    Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
    Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms.
    Hemminger J; Iwenofu OH
    Histopathology; 2012 Aug; 61(2):170-7. PubMed ID: 22571292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
    Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOG1 immunoreactivity in uterine leiomyosarcomas.
    Sah SP; McCluggage WG
    J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (non-GIST) neoplasms.
    Tang YL; Wong CF; Yap WM; Chuah KL
    Histopathology; 2014 Nov; 65(5):724-6. PubMed ID: 24713079
    [No Abstract]   [Full Text] [Related]  

  • 14. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
    Swalchick W; Shamekh R; Bui MM
    Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of DOG1 immunohistochemistry in dermatopathology.
    Goto K
    J Cutan Pathol; 2016 Nov; 43(11):974-983. PubMed ID: 27506854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.
    Parfitt JR; Rodriguez-Justo M; Feakins R; Novelli MR
    Histopathology; 2008 Jun; 52(7):816-23. PubMed ID: 18494611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
    Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
    Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia.
    Bousdras K; O'Donnell P; Vujovic S; Henderson S; Boshoff C; Flanagan AM
    Histopathology; 2007 Sep; 51(3):414-6. PubMed ID: 17727486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.